Doyle Noah Insider Trades

Insider Trading History

Track insider trading activity for Doyle Noah. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $2.26M 704,780 shares
Last Trade
Mar 12, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.4B 500,000 shares
$2,790.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $3.87M 1,204,780 shares
Last Trade
Feb 25, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.28B 500,000 shares
$2,562.50
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $0 0 shares
Last Trade
Feb 25, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.28B 500,000 shares
$2,562.50
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner
Holding Value $38.5k 12,000 shares
Last Trade
Jan 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.5M 12,000 shares
$2,787.50
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner
Holding Value $48.2k 15,000 shares
Last Trade
Feb 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112M 15,000 shares
$7,497.50
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner
Holding Value $96.3k 30,000 shares
Last Trade
Jan 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27B 30,000 shares
$42,375.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner
Holding Value $22.6M 7,047,804 shares
Last Trade
Oct 03, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$455B 10,000,000 shares
$45,475.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $6.57M 2,047,804 shares
Last Trade
Jun 29, 2015 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$866B 1,570,557 shares
$551,250.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $0 0 shares
Last Trade
Jun 29, 2015 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$178B 322,753 shares
$551,250.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $2.57M 800,000 shares
Last Trade
Jun 24, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$496B 800,000 shares
$620,000.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $0 0 shares
Last Trade
Jun 24, 2015 Sale
$825B 1,331,028 shares
$620,000.00
$3.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up